SCHEMBL27304337

SCHEMBL27304337

NN1CCCCC1Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.45
▸ DPP4 P27487 1/20 0.43
▸ SLC18A3 Q16572 1/20 0.43
▸ PRMT3 O60678 1/20 0.42
▸ CARM1 Q86X55 1/20 0.42
▸ PRMT6 Q96LA8 1/20 0.42
▸ PRMT1 Q99873 1/20 0.42
▸ PRMT8 Q9NR22 1/20 0.42
▸ ABHD6 Q9BV23 4/20 0.42
▸ DAGLA Q9Y4D2 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL8844004 0.87 DPP4 (0.47) HSD11B1DPP4ABHD6DAGLA
SCHEMBL21599161 0.79 — —
SCHEMBL27630337 0.79 PRMT3 (0.44) HSD11B1PRMT3CARM1PRMT6PRMT1
SCHEMBL10999601 0.79 MEN1 (0.47) SLC18A3
SCHEMBL350911 0.79 HSD11B1 (0.48) HSD11B1DPP4SLC18A3ABHD6DAGLA
SCHEMBL2606119 0.79 ADRA2A (0.53) —
SCHEMBL7413375 0.79 HSD11B1 (0.45) HSD11B1SLC18A3ABHD6DAGLA
SCHEMBL21599187 0.78 MC4R (0.46) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL27869836 0.78 HSD11B1 (0.42) HSD11B1SLC18A3PRMT3CARM1PRMT6
SCHEMBL7264069 0.78 KCNH2 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1617743-A New pharmaceutical combinations for nos inhibitors PFIZER PROD INC (US) 2005-05-18 — — CN claimed
CN-1529600-A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses �Ʒ� 2004-09-15 — — CN claimed
CN-1082371-C NK-1 receptor antagonists and 5HT for the treatment of emesis3Receptor antagonists PFIZER (US) 2002-04-10 — — CN claimed
CN-1132625-A NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis PFIZER (US) 1996-10-09 — — CN claimed
CN-1132072-A NK-1 receptor antagonists for the treatment of nerve injury and stroke PFIZER (US) 1996-10-02 — — CN claimed
CN-108409738-B 3, 4-methylenedioxyphenyl substituted tetrahydro-beta-carboline piperazine diketone derivative and application thereof 华东理工大学 2020-10-16 — — CN disclosed
CN-108409737-B 4-methoxyphenyl substituted tetrahydro- β -carboline piperazine diketone derivative and application thereof 华东理工大学 2020-07-03 — — CN disclosed
CN-1617743-A New pharmaceutical combinations for nos inhibitors PFIZER PROD INC (US) 2005-05-18 — — CN disclosed
CN-1529600-A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses �Ʒ� 2004-09-15 — — CN disclosed
CN-1082371-C NK-1 receptor antagonists and 5HT for the treatment of emesis3Receptor antagonists PFIZER (US) 2002-04-10 — — CN disclosed
CN-1045595-C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives PFIZER (US) 1999-10-13 — — CN disclosed
CN-1035944-C 3-aminopiperidine derivatives and related nitrogen-containing heterocyclic compounds PFIZER (US) 1997-09-24 — — CN disclosed
CN-1132625-A NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis PFIZER (US) 1996-10-09 — — CN disclosed
CN-1132072-A NK-1 receptor antagonists for the treatment of nerve injury and stroke PFIZER (US) 1996-10-02 — — CN disclosed
CN-1087083-A The intermediates preparation of synthetic 3-amino piperidine derivatives PFIZER (US) 1994-05-25 — — CN disclosed
CN-1065264-A The stereoselectivity preparation method of the piperidines that replaces PFIZER (US) 1992-10-14 — — CN disclosed
CN-1053060-A 3-aminopiperidine derivatives and related nitrogen-containing heterocycles PFIZER (US) 1991-07-17 — — CN disclosed
Send feedback